:: Altroz - News Magazine HTML Template ::

Language:

Aurobindo Pharma News

Aurobindo Pharma's Hyderabad API Unit Faces USFDA Inspection with Two Observations

Ryan Peterson 18 Dec, 2024

Aurobindo Pharma reports that the USFDA inspected its subsidiary Apitoria Pharma's API manufacturing facility in Hyderabad with two procedural observations, to be addressed within ...

Business

Aurobindo Pharma's CuraTeQ Secures Positive EMA Opinion for Zefylti Biosimilar

Emily Rodriguez 17 Dec, 2024

CuraTeQ Biologics, a subsidiary of Aurobindo Pharma, received a positive opinion from EMA's CHMP for its filgrastim biosimilar, Zefylti. This marks the first biosimilar from Aurobi...